Laporan Laba Rugi (TTM)
Laporan Laba Rugi X Bioscience Public Company Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 480 | 416 | 410 | 377 | 353 | 254 | 237 | 237 | 232 | 344 | 347 | 337 | 332 | 312 | 307 | 301 | 297 | 319 | 297 | 252 |
Change (%) | -13.38 | -1.40 | -8.12 | -6.18 | -28.09 | -6.88 | 0.05 | -1.80 | 48.23 | 0.62 | -2.90 | -1.36 | -6.09 | -1.56 | -1.95 | -1.32 | 7.51 | -7.04 | -15.21 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 350 | 286 | 262 | 212 | 185 | 127 | 119 | 116 | 108 | 172 | 174 | 169 | 166 | 160 | 159 | 161 | 161 | 181 | 175 | 148 |
Change (%) | -18.23 | -8.22 | -19.24 | -12.63 | -31.53 | -5.77 | -2.63 | -6.95 | 59.14 | 1.07 | -2.88 | -1.87 | -3.79 | -0.28 | 0.95 | 0.21 | 12.15 | -3.18 | -15.58 | |
% of Revenue | 72.90 | 68.81 | 64.05 | 56.30 | 52.43 | 49.92 | 50.51 | 49.16 | 46.59 | 50.02 | 50.24 | 50.25 | 49.99 | 51.21 | 51.88 | 53.41 | 54.24 | 56.58 | 58.93 | 58.68 |
Gross Operating Profit | 130 | 130 | 147 | 165 | 168 | 127 | 117 | 120 | 124 | 172 | 172 | 167 | 166 | 152 | 148 | 140 | 136 | 139 | 122 | 104 |
Change (%) | -0.32 | 13.66 | 11.69 | 2.13 | -24.30 | -7.99 | 2.78 | 3.17 | 38.71 | 0.18 | -2.93 | -0.84 | -8.39 | -2.90 | -5.08 | -3.07 | 2.00 | -12.08 | -14.68 | |
% of Revenue | 27.10 | 31.19 | 35.95 | 43.70 | 47.57 | 50.08 | 49.49 | 50.84 | 53.41 | 49.98 | 49.76 | 49.75 | 50.01 | 48.79 | 48.12 | 46.59 | 45.76 | 43.42 | 41.07 | 41.32 |
SG&A | 225 | 261 | 306 | 379 | 441 | 228 | 180 | 130 | 85 | 455 | 452 | 443 | 432 | 273 | 288 | 298 | 305 | 390 | 382 | 415 |
Change (%) | 15.88 | 17.27 | 23.73 | 16.40 | -48.38 | -21.03 | -27.79 | -34.80 | 437.72 | -0.73 | -2.02 | -2.57 | -36.85 | 5.58 | 3.72 | 2.16 | 27.86 | -2.13 | 8.86 | |
% of Revenue | 46.99 | 62.86 | 74.76 | 100.68 | 124.91 | 89.66 | 76.04 | 54.89 | 36.44 | 132.20 | 130.42 | 131.60 | 129.98 | 87.41 | 93.75 | 99.18 | 102.67 | 122.11 | 128.56 | 165.06 |
R&D | ||||||||||||||||||||
Change (%) | ||||||||||||||||||||
% of Revenue | ||||||||||||||||||||
OpEx | 575 | 547 | 569 | 591 | 626 | 355 | 299 | 246 | 193 | 628 | 626 | 612 | 598 | 432 | 447 | 459 | 466 | 570 | 556 | 563 |
Change (%) | -4.86 | 3.95 | 3.91 | 5.99 | -43.40 | -15.57 | -17.74 | -21.64 | 225.30 | -0.24 | -2.26 | -2.38 | -27.67 | 3.41 | 2.74 | 1.47 | 22.43 | -2.46 | 1.17 | |
% of Revenue | 119.89 | 131.67 | 138.81 | 156.98 | 177.34 | 139.58 | 126.56 | 104.05 | 83.03 | 182.22 | 180.66 | 181.86 | 179.97 | 138.63 | 145.63 | 152.59 | 156.91 | 178.69 | 187.49 | 223.73 |
Operating Income | -95 | -132 | -159 | -215 | -273 | -101 | -63 | -10 | 39 | -283 | -280 | -275 | -266 | -120 | -140 | -158 | -169 | -251 | -260 | -311 |
Change (%) | 37.96 | 20.83 | 34.89 | 27.34 | -63.19 | -37.53 | -84.74 | -511.30 | -818.15 | -1.28 | -1.47 | -3.63 | -54.64 | 16.28 | 13.01 | 6.79 | 48.65 | 3.36 | 19.91 | |
% of Revenue | -19.89 | -31.67 | -38.81 | -56.98 | -77.34 | -39.58 | -26.56 | -4.05 | 16.97 | -82.22 | -80.66 | -81.86 | -79.97 | -38.63 | -45.63 | -52.59 | -56.91 | -78.69 | -87.49 | -123.73 |
Interest Expense | -16 | -17 | -15 | -13 | -12 | -14 | -18 | -22 | -26 | -57 | -62 | -66 | -68 | -40 | -38 | -36 | -35 | -34 | -30 | -29 |
Change (%) | 4.01 | -11.81 | -12.73 | -5.41 | 19.67 | 22.61 | 23.53 | 19.10 | 116.90 | 9.44 | 7.17 | 2.86 | -41.42 | -4.74 | -4.79 | -4.63 | -0.75 | -12.78 | -1.38 | |
% of Revenue | -3.32 | -3.99 | -3.57 | -3.39 | -3.42 | -5.69 | -7.49 | -9.24 | -11.21 | -16.41 | -17.84 | -19.69 | -20.54 | -12.81 | -12.40 | -12.04 | -11.63 | -10.74 | -10.08 | -11.72 |
Net Income | -213 | -239 | -268 | -317 | -372 | -276 | -305 | -345 | -373 | -576 | -515 | -429 | -355 | -148 | -166 | -184 | -190 | -260 | -291 | -329 |
Change (%) | 12.37 | 12.17 | 18.23 | 17.60 | -25.78 | 10.33 | 13.01 | 8.13 | 54.53 | -10.54 | -16.77 | -17.31 | -58.40 | 12.40 | 10.74 | 3.63 | 36.75 | 11.99 | 12.98 | |
% of Revenue | -44.29 | -57.46 | -65.37 | -84.11 | -105.43 | -108.82 | -128.94 | -145.65 | -160.39 | -167.20 | -148.65 | -127.43 | -106.82 | -47.32 | -54.03 | -61.02 | -64.08 | -81.51 | -98.20 | -130.85 |
Source: Capital IQ